These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Plasma apolipoproteins: their role in cardiovascular diseases and usefulness of their blood concentration determination. Committee of the Study of Apolipoproteins, Italian Heart Foundation]. Cardiologia; 1997 Feb; 42 Suppl 1():1-39. PubMed ID: 9147845 [No Abstract] [Full Text] [Related]
3. Effect of elective hospitalization on plasma lipoprotein cholesterol and apolipoproteins A-I, B and Lp(a). Genest JJ; McNamara JR; Ordovas JM; Martin-Munley S; Jenner JL; Millar J; Salem DN; Schaefer EJ Am J Cardiol; 1990 Mar; 65(9):677-9. PubMed ID: 2106773 [No Abstract] [Full Text] [Related]
5. [Diagnosis of high risk of heart disease among asymptomatic persons]. Holme I; Hjermann I Tidsskr Nor Laegeforen; 2002 Sep; 122(21):2132-3. PubMed ID: 12555653 [No Abstract] [Full Text] [Related]
6. Immunoassays: a roadmap for the 1980s. Eby WC; Berk LS Am J Med Technol; 1982 Aug; 48(8):645-50. PubMed ID: 6753579 [TBL] [Abstract][Full Text] [Related]
7. Policy on characterization of antibodies used in immunochemical methods of analysis for mycotoxins and phycotoxins. Fremy JM; Usleber E J AOAC Int; 2003; 86(4):868-71. PubMed ID: 14509448 [TBL] [Abstract][Full Text] [Related]
9. Radioimmunoassay of human arginine-rich apolipoprotein, apoprotein E. Concentration in blood plasma and lipoproteins as affected by apoprotein E-3 deficiency. Havel RJ; Kotite L; Vigne JL; Kane JP; Tun P; Phillips N; Chen GC J Clin Invest; 1980 Dec; 66(6):1351-62. PubMed ID: 7440719 [TBL] [Abstract][Full Text] [Related]
10. Optimisation of sandwich ELISA based on monoclonal antibodies for the specific measurement of pregnancy-associated plasma protein (PAPP-A) in acute coronary syndrome. Rossen M; Iversen K; Teisner A; Teisner B; Kliem A; Grudzinskas G Clin Biochem; 2007 Apr; 40(7):478-84. PubMed ID: 17316591 [TBL] [Abstract][Full Text] [Related]
11. [Protein C and apoprotein levels in ischemic heart disease diagnosed by coronarography]. Orosz L; Altorjay I; Hársfalvl J; Voith L Orv Hetil; 1989 May; 130(19):987-9. PubMed ID: 2657571 [TBL] [Abstract][Full Text] [Related]
12. [Quantification and clinical significance of plasma apolipoproteins]. Nakai T; Oida K Rinsho Byori; 1990 Feb; 38(2):125-34. PubMed ID: 2109805 [TBL] [Abstract][Full Text] [Related]
13. Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men. Sigurdsson G; Baldursdottir A; Sigvaldason H; Agnarsson U; Thorgeirsson G; Sigfusson N Am J Cardiol; 1992 May; 69(16):1251-4. PubMed ID: 1585854 [TBL] [Abstract][Full Text] [Related]
14. [Specific antibodies in technics of radioimmunological analysis]. Piven' NV Med Radiol (Mosk); 1986 Dec; 31(12):87-93. PubMed ID: 3540516 [No Abstract] [Full Text] [Related]
15. [Application of monoclonal antibodies to the assay of apolipoproteins]. Marcel YL; Weech PK; Milne RW Ann Biol Clin (Paris); 1986; 44(5):536-44. PubMed ID: 2433973 [TBL] [Abstract][Full Text] [Related]
16. Serum apolipoprotein measurements: an improved discriminator for assessing coronary heart disease risk. Naito HK Compr Ther; 1987 Nov; 13(11):43-52. PubMed ID: 3315418 [No Abstract] [Full Text] [Related]
17. [Apolipoproteins and coronary heart disease]. Beigl Y; Green P; Lurie Y Harefuah; 1987 Apr; 112(8):405-7. PubMed ID: 3315898 [No Abstract] [Full Text] [Related]